Haemonetics sells facility in South Carolina to CSL Plasma
Haemonetics and CSL Plasma announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma. The facility produces liquid saline and sodium citrate, which are solutions used in the plasmapheresis, or plasma collection, process. CSL Plasma provides plasma to global biotechnology leader CSL Under the terms of the agreement, at closing of the transaction CSL Plasma will obtain ownership and operational control of the facility, including property and equipment. In addition, through this transaction approximately 200 Haemonetics employees working in the Union, South Carolina, facility will be given the opportunity to become CSL Plasma employees. The transaction is expected to close within the current quarter, subject to the satisfaction of various closing conditions and a regulatory notification. Haemonetics also announced that it has updated its FY20 guidance assuming the closing of the transaction, which is available on the Haemonetics Investor Relations website.